Skip to main content
  • Home
  • About
  • Faculty Experts
  • For The Media
  • ’Cuse Conversations Podcast
  • Topics
    • Alumni
    • Events
    • Faculty
    • Students
    • All Topics
  • Contact
  • Submit
  • All News
  • Arts & Culture
  • Business & Economy
  • Campus & Community
  • Health & Society
  • Media, Law & Policy
  • STEM
  • Veterans
  • |
  • Alumni
  • The Peel
  • Athletics
Sections
  • All News
  • Arts & Culture
  • Business & Economy
  • Campus & Community
  • Health & Society
  • Media, Law & Policy
  • STEM
  • Veterans
  • |
  • Alumni
  • The Peel
  • Athletics
  • Home
  • About
  • Faculty Experts
  • For The Media
  • ’Cuse Conversations Podcast
  • Topics
    • Alumni
    • Events
    • Faculty
    • Students
    • All Topics
  • Contact
  • Submit

Syracuse University and Emisphere Technologies Inc. enter into research agreement to test oral drug delivery systems

Monday, June 22, 2009, By News Staff
Share

Syracuse University and Emisphere Technologies Inc. enter into research agreement to test oral drug delivery systemsJune 22, 2009Judy Holmesjlholmes@syr.edu

Syracuse University and Emisphere Technologies Inc. (OTC BB: EMIS.OB) have entered into a research agreement to combine Emisphere’s proprietary Eligen® oral drug delivery technology with a new oral drug delivery system developed in the laboratory of Robert Doyle, assistant professor of chemistry in SU’s College of Arts and Sciences. The experiments will test whether the combination of Eligen® and Doyle’s oral drug delivery technology will enhance the absorption of an appetite-suppressing hormone.

“We are very pleased to announce our collaboration with Syracuse University,” says Michael V. Novinski, president and chief executive officer of Emisphere. “Dr. Doyle and his colleagues have successfully developed innovative methods for the oral delivery of both proteins and peptides using novel methods. We therefore see a significant potential for innovation in this partnership and an opportunity for further expansion for the use of our Eligen® technology in the drug delivery arena.”

Researchers in Doyle’s lab are trying to find a way to create an appetite-suppressing drug using PYY that can be taken orally rather than by injection. PYY is a hormone that is released by the cells lining the small intestine after people eat, which signals feelings of “fullness.” Recent research has shown that the higher the level of PYY in the bloodstream, the greater the feeling of fullness.

“The Eligen® technology platform has shown great promise for improving the body’s ability to absorb both small and large molecule drugs,” Doyle says. “Of great interest to us is its ability to overcome the limited natural absorption of our vitamin-based carrier, which will enable us to achieve significant advancements in oral protein/peptide delivery. We are excited about the opportunity to leverage their technology in our ongoing research.”

About Emisphere Technologies Inc.

Emisphere is a biopharmaceutical company that focuses on a unique and improved delivery of therapeutic molecules or nutritional supplements using its Eligen® technology. These molecules and compounds could be currently available or in development. Such molecules are usually delivered by injection; in many cases, their benefits are limited due to poor bioavailability, slow on-set of action or variable absorption. The Eligen® technology can be applied to the oral route of administration as well other delivery pathways, such as buccal, rectal, inhalation, intra-vaginal or transdermal. The company’s website is http://www.emisphere.com.

About Syracuse University

Chartered in 1870 as a private, coeducational institution of higher education, Syracuse University is a leading national research university of more than 18,000 full- and part-time students from all 50 states and 90 countries, and more than 1,400 faculty members. Syracuse University is propelled by the bold idea of Scholarship in Action–education that is not static, but the living expression of insight that drives change. It is a place where students become leaders, teachers, and collaborators and where the community is continually impacted by the energy of new ideas. The Doyle lab webpage is http://www-che.syr.edu/faculty/doyle.html.

  • Author

News Staff

  • Recent
  • 2023-24 Parking Rates Announced
    Friday, May 26, 2023, By News Staff
  • Lutheran Chaplain Announces Retirement
    Thursday, May 25, 2023, By Dara Harper
  • SyracuseCoE Awards $180,000 for 9 Faculty Fellow Projects Supporting Research and Innovation
    Thursday, May 25, 2023, By News Staff
  • From Generation to Generation: Doing Well by Doing Good
    Thursday, May 25, 2023, By Eileen Korey
  • Office of Veteran and Military Affairs Celebrates Graduating Military-Connected Students
    Wednesday, May 24, 2023, By Charlie Poag

More In Uncategorized

Syracuse Views Spring 2023

We want to know how you experience Syracuse University. Take a photo and share it with us. We select photos from a variety of sources. Submit photos of your University experience using #SyracuseU on social media, fill out a submission…

Awards of Excellence Honoree: Maxwell has Been ‘a Guiding Hand’ in Public Service Career

Standing before an audience of fellow Maxwell School alumni gathered in Washington, D.C., for the second annual Maxwell Awards of Excellence, CNN anchor Boris Sanchez ’09 shared the motivation behind his work as a journalist. Sanchez emigrated from Cuba as…

NASA Honoring Those Who Were Aboard Space Shuttle Columbia And Other Late Astronauts

Sean O’Keefe, University Professor in the Maxwell School, was interviewed for the USA Today article “Twenty years later, loss of space shuttle Columbia still teaches us lessons.” The article emphasizes how NASA’s Memorial Grove is used to honor late astronauts,…

NFL, Eagles and Chiefs All Set To Win The Economics Game In Super Bowl LVII

Rodney Paul, director and professor of sport analytics in the Falk School, was quoted in the Washington Examiner story “The economics of the Super Bowl: Hosting, gambling, ads, and more.” The article talks in-depth about all of the economics that…

CEOs Requiring In Person Work Is Hurting Diversity

Arlene Kanter, director of the Disability and Policy Program and professor in the College of Law, was interviewed for the Business Insider article “Some CEOs are pushing workers to return to the office, but it could come with a cost:…

Subscribe to SU Today

If you need help with your subscription, contact sunews@syr.edu.

Connect With Us

  • Twitter
  • Facebook
  • Instagram
  • Youtube
  • LinkedIn
Social Media Directory

For the Media

Find an Expert Follow @SyracuseUNews
  • Facebook
  • Instagram
  • Youtube
  • LinkedIn
  • @SyracuseU
  • @SyracuseUNews
  • @SUCampus
  • Social Media Directory
  • Accessibility
  • Privacy
  • Campus Status
  • Syracuse.edu
© 2023 Syracuse University News. All Rights Reserved.